Gout and risk of Parkinson disease: a prospective study.
ABSTRACT
Objective: To estimate prospectively the association between gout
diagnosis and the risk of PD.
Methods: We conducted a case-control study nested in the General
Practice Research Database, a computerized database that gathers
information on more than 3 million Britons followed up by their general
practitioners. PD cases occurring between January 1995 and December 2001
were identified, and matched with up to 10 controls by sex, age,
practice, and start of follow-up. We obtained information on history of
gout and use of anti-gout medication using the computerized medical
records.
Results: During the study period, we identified 1,052 PD cases and 6,634
controls. Individuals with previous history of gout had a lower risk of
developing PD (OR 0.69, 95% CI 0.48, 0.99). This association was evident
among men (OR 0.60, 95% CI 0.40, 0.91) but not among women (OR 1.26, 95%
CI 0.57, 2.81; p for interaction: 0.11). Initiation of anti-gout
medication was associated with a lower risk of PD (OR 0.57, 95% CI 0.19,
1.70).
Conclusion: Gout is associated with a lower risk of Parkinson disease
(PD). Our findings provide additional support for a potential link
between uric acid and PD. Further research is required to explore a
potential effect modification by sex.
Background: Several reports suggest that higher levels of serum uric
acid are associated with a lower risk of Parkinson disease (PD). None of
these studies, however, evaluated the potential association between
gout, a condition characterized by hyperuricemia, and the risk of PD.